The Phase 3 CELLEBRATE trial to test a regenerative stem cell-based therapy in treating patients with stress urinary incontinence is continuing to recruit additional subjects after changing its study protocol to include only patients who have already tried surgery. 

Young Cameron Campbell recently became the first pediatric patient to receive a living donor liver transplant at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

In the first such procedure, Vanderbilt University Medical Center has transplanted a DCD (donation after cardiac death) heart using XVIVO Heart Assist Transport (XHAT), a novel cold organ perfusion device.

The Vanderbilt Transplant Center established a new record in calendar year 2023 for total solid organ transplants, performing 739 lifesaving procedures among its adult and pediatric organ transplant programs.

17-year-old Lucy Scherba's liver transplant represented a new milestone for Monroe Carell Jr. Children’s Hospital at Vanderbilt.

A study by Vanderbilt researchers has revealed how metabolic changes spurred by fatty acids contribute to the transformation of cells into abnormal versions of themselves that are the precursors to stomach cancer.

Connie Rankin of Memphis, Tennessee, received Vanderbilt's first combined lung and liver transplant, which involved dozens of specialists, including transplant teams for both organs.